Technetium-99m Labeling
Technetium-99m Labeling - Related Videos
10:54
Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
0 Views •
Cited by 7 •
2017
Here, we describe a protocol for radiolabeling and in vivo testing of tridentate 99mTc(I) chelate-tetrazine derivatives for pre-targeting and bioorthogonal chemistry.
07:52
In Vivo Imaging and Tracking of Technetium-99m Labeled Bone Marrow Mesenchymal Stem Cells in Equine Tendinopathy
0 Views •
Cited by 17 •
2015
This protocol describes the radiolabeling of equine mesenchymal stem cells and their implantation into tendon injuries in the horse in order to determine cell survival and tissue distribution using gamma scintigraphy.
09:19
Simultaneous Label-Free Autofluorescence Multi-Harmonic Microscopy
0 Views •
Cited by 3 •
2025
This protocol presents a step-by-step guide for the Simultaneous Label-free Autofluorescence Multi-harmonic (SLAM) microscopic technique, including details on how to generate the laser light source, prepare a tissue sample, conduct imaging, and analyze the data. SLAM advances nonlinear microscopy by measuring four complementary label-free contrasts to investigate the tissue microenvironment.
08:28
Metabolic Labeling
0 Views •
2023
Metabolic labeling is used to probe the biochemical transformations and modifications that occur in a cell. This is accomplished by using chemical analogs that mimic the structure of natural biomolecules. Cells utilize analogs in their endogenous biochemical processes, producing compounds that are labeled. The label allows for the incorporation of detection and affinity tags, which can then be used to elucidate metabolic pathways using other biochemical analytical techniques, such as SDS-PAGE...
01:20
Labeling Emotion
0 Views •
2025
Emotional labeling is a cognitive process that involves identifying and naming one's emotions, such as anger, fear, happiness, or sadness. It allows individuals to recognize and express their internal emotional states, a critical aspect of emotional regulation and communication. Labeling emotions requires more than mere recognition; it also involves drawing upon memory and contextual cues to understand the current situation and apply a corresponding emotional label. For instance, feeling...
FAQs
Chemical reduction changes technetium from the pertechnetate form into a state that can coordinate with a chelator or bind to a carrier molecule. Stannous ions commonly provide this reducing action. Without this step, the radionuclide would not be prepared for attachment to the drug, peptide, or other targeting compound used in the imaging agent.
Chelators provide chemical sites that hold reduced technetium, whereas carrier molecules help direct the labeled compound toward selected tissues. The carrier may be a drug, peptide, or another targeting compound. Their combined roles connect radionuclide chemistry with biological distribution, allowing the eventual image to reflect tissue localization rather than merely the presence of radioactivity.
As technetium-99m decays, it emits gamma photons with an energy of 140 keV. Gamma cameras and SPECT systems detect this signal and use it to produce images of where the labeled agent has accumulated. Because the distribution corresponds to selected tissues, the detected pattern can reveal organ function, blood flow, or disease-related changes.
The biological destination of the carrier determines which tissue contributes most strongly to the detected signal. Accumulation in selected tissues allows imaging to emphasize functional behavior, blood flow, or changes associated with disease. Thus, labeling chemistry and carrier selection influence the clinical information available, not simply the visibility of the radionuclide.
A typical preparation begins with sodium pertechnetate containing technetium-99m. The technetium is then chemically reduced, often using stannous ions, so it can coordinate with a chelator or bind to a carrier such as a drug or peptide. The resulting labeled compound is administered for imaging, after which emitted photons are detected by nuclear medicine equipment.
Gamma cameras detect the 140-keV gamma photons emitted by technetium-99m, while SPECT systems use the same detectable radiation to visualize its distribution in three dimensions. These systems translate the radioactive pattern into images that can show organ function, blood flow, and disease-related changes, supporting diagnostic assessment in nuclear medicine.
Technetium-99m labeling is useful when clinicians need diagnostic information about how an organ functions, how blood moves through tissue, or where disease-related changes may occur. Different carrier molecules can direct the radionuclide toward selected tissues, while gamma-camera or SPECT detection provides the corresponding functional or distributional image with relatively low radiation exposure.